This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.

HB1424: (New Title) establishing a pharmaceutical study commission to study direct purchasing of prescription medication by the state.

Bill details

Version history, amendments, and roll-call votes were not present in the imported local bill data.

Sponsors

Topics

INTERSTATE COOPERATION

Official links

HB 1424-FN-A - AS AMENDED BY THE HOUSE

17Mar2004... 0742h

2004 SESSION

04-2350

08/09

HOUSE BILL 1424-FN-A

AN ACT establishing a pharmaceutical study commission to study direct purchasing of prescription medication by the state.

AMENDED ANALYSIS

This bill establishes a commission to study direct purchasing of prescription medication by the state for resale to retail pharmacies.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

17Mar2004... 0742h

04-2350

08/09

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Four

AN ACT establishing a pharmaceutical study commission to study direct purchasing of prescription medication by the state.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 Commission Established. There is established a pharmaceutical study commission to study direct purchasing of prescription medication by the state for resale to retail pharmacies.

2 Membership and Compensation.

I. The members of the commission shall be as follows:

(a) Three members of the house of representatives, appointed by the speaker of the house.

(b) Three members of the senate, appointed by the president of the senate.

(c) One representative appointed by the New Hampshire Independent Pharmacist Association.

(d) One representative appointed by the National Association of Chain Drug Stores.

(e) One representative appointed by the American Pharmaceutical Association.

(f) One representative appointed by the Pharmaceutical Research and Manufacturers of America.

(g) One representative appointed by the American Association of Retired Persons.

II. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.

3 Duties. The commission shall study which drug plans have the greatest potential for savings, the methods for purchasing drugs from manufacturers, the methods of distribution, and any other issue necessary for the state to act as a wholesale distributor of prescription medication.

4 Chairperson; Quorum. The members of the study commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the first-named house member. The first meeting of the commission shall be held within 45 days of the effective date of this section. Four members of the commission shall constitute a quorum.

5 Report. The commission shall report its findings and any recommendations for proposed legislation to the speaker of the house of representatives, the president of the senate, the house clerk, the senate clerk, the governor, and the state library on or before November 1, 2004.

6 Effective Date. This act shall take effect upon its passage.

LBAO

04-2350

Amended 3/19/04

HB 1424 FISCAL NOTE

AN ACT establishing a pharmaceutical study commission to study direct purchasing of prescription medication by the state.

FISCAL IMPACT:

The Office of Legislative Budget Assistant has determined this bill, as amended by the House, (Amendment #2004-0742h), will have no fiscal impact on state, county, and local revenue or expenditures.

METHODOLOGY:

The Office states this bill creates a study commission and as such will have no fiscal impact.